• Ya-Nan Zong, Chuan-Ya Xu, Yue-Qing Gong, Xiao-Qing Zhang, Hong Zeng, Chang Liu, Bin Zhang, Li-Xiang Xue, Xiang-Yang Guo, Feng Wei, and Yi Li.
• Department of Anesthesiology, Peking University Third Hospital, No.49 Huayuanbei Road, Beijing, 100191, People's Republic of China.
• BMC Anesthesiol. 2022 Jul 12; 22 (1): 217.

BackgroundTo compare the effectiveness of intraoperative cell salvage (IOCS) combined with a modified leucocyte depletion filter (MLDF) with IOCS combined with a regular leucocyte depletion filter (RLDF) in eliminating tumour cells from blood salvage during metastatic spine tumour surgery (MSTS).MethodsPatients with a known primary epithelial tumour who underwent MSTS were recruited for this study. Blood samples were collected in 5 stages: from the patients' vein before anaesthesia induction (S1), from the operative field at the time of maximum tumour manipulation (S2), and from the operative blood after IOCS processing (S3) and after IOCS+RLDF (S4) and IOCS+MLDF (S5) processing. The polyploids of tumour cells in the blood samples were collected and counted with immunomagnetic separation enrichment and fluorescence in situ hybridization.ResultsWe recruited 20 patients. Tumour cells were detected in 14 patients (70%) in S1, 16 patients (80%) in S2, 13 patients (65%) in S3, and 12 patients (60%) in S4. MLDF was added in 8 patients. Tumour cells were detected in only 1 of 8 patients in S5 (12.5%). There were significantly fewer tumour cells in the samples collected after MLDF processing (S5) than in the samples collected after RLDF (S4) and around the tumour (S2) (P = 0.016 and P = 0.039, respectively). Although no significant difference was observed between S4 and S1, a downward trend was observed after IOCS+RLDF processing.ConclusionsTumour cells could be removed by IOCS combined with RLDF from blood salvaged during MSTS, but residual tumour cells remained. The findings support the notion that MLDF eliminates tumour cells more effectively than RLDF. Hence, this technique can be applied to MSTS.Trial RegistrationChiCTR1800016162 Chinese Clinical Trial Registry.© 2022. The Author(s).

10 keywords...

hide…